HEART TRANSPLANTATION IN THE KRASNODAR REGION: 3-YEAR SINGLE CENTRE EXPERIENCE
We retrospectively reviewed the cases of 108 patients, who underwert ortotopic heart transpalantation between march 2010 and june 2013. The main causes of end-stage heart failure was dilated (60% of cases) and ischemic cardiomyopathy (37% of cases). Time patients monitoring ranged from 2 to 36 months. Survival analysis was conducted by the method of Kaplan-Meier. Hospital mortality was 6,48% (n=7). The main cause of death in this period were infectious and septic complications. The frequent complications during the hospital period were pneumonia hospital in 14,8% of cases, violations of cardiac arrhythmias and conduction in 13,8% of cases, diagnosis of (de novo) diabetes mellitus in 13% of cases. The mortality rate for 3 year amounted 10,2% (n=11). The causes of death in the remote period were the reaction of the transplant rejection with the development of dysfunction in 49,5% of cases (5 patients), sarcoma of the heart, acute violation of cerebral circulation. Three-year survival rate was 83,64%. Heart transplantation is only effective treatment for patients with end-stage heart failure. Our experience HT demonstrates good results that are comparable with those of the international community ISHLT.